The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
SMS Pharmaceuticals has reported total income of Rs. 196.64 crores during the period ended June 30, 2025
KIMS has reported total income of Rs. 878.7 crores during the period ended June 30, 2025
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Subscribe To Our Newsletter & Stay Updated
